We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+5.99%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.75B
AUM Growth
-$39.4M
(-0.68%)
Cap. Flow
-$636M
Cap. Flow
% of AUM
-11.06%
Top 10 Holdings %
Top 10 Hldgs %
22.09%
Holding
798
New
336
Increased
102
Reduced
128
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CFN
CAREFUSION CORPORATION
CFN
|
+$125M |
| 2 |
CVD
COVANCE INC.
CVD
|
+$75.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$71.6M |
| 4 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$69.7M |
| 5 |
PepsiCo
PEP
|
+$52.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$72.3M |
| 2 |
NCR Voyix
VYX
|
+$64.1M |
| 3 |
Humana
HUM
|
+$64M |
| 4 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$63.4M |
| 5 |
TSMC
TSM
|
+$62.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.85% |
| 2 | Consumer Discretionary | 11.63% |
| 3 | Consumer Staples | 10.69% |
| 4 | Industrials | 10.3% |
| 5 | Technology | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Voya Financial
VOYA
$9.26B
| $336K | 0.01% |
+7,922
| New | +$317K |
|
|
VMW
477
DELISTED
VMware, Inc
VMW
| $336K | 0.01% |
+4,066
| New | +$347K |
|
478
Grand Canyon Education
LOPE
$3.96B
| $335K | 0.01% |
+7,180
| New | +$320K |
|
|
AFSI
479
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $335K | 0.01% |
+11,896
| New | +$299K |
|
480
Autodesk
ADSK
$52.6B
| $333K | 0.01% |
+5,543
| New | +$321K |
|
|
PLCM
481
DELISTED
POLYCOM INC
PLCM
| $331K | 0.01% |
+24,513
| New | +$313K |
|
|
LDRH
482
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $328K | 0.01% |
+10,000
| New | +$328K |
|
483
Steven Madden
SHOO
$3.54B
| $326K | 0.01% |
+15,383
| New | +$328K |
|
|
INVN
484
DELISTED
Invensense Inc
INVN
| $325K | 0.01% |
+20,000
| New | +$336K |
|
485
Arrow Electronics
ARW
$10.3B
| $324K | 0.01% |
+5,590
| New | +$311K |
|
486
Macerich
MAC
$6.83B
| $323K | 0.01% |
3,868
-7,510
| -66% | -$553K |
|
487
Boston Scientific
BSX
$71.5B
| $322K | 0.01% |
+24,302
| New | +$311K |
|
|
RPXC
488
DELISTED
RPX Corporation
RPXC
| $312K | 0.01% |
+22,645
| New | +$314K |
|
|
BRCM
489
DELISTED
BROADCOM CORP CL-A
BRCM
| $312K | 0.01% |
+7,210
| New | +$295K |
|
|
BMR
490
DELISTED
BIOMED REALTY TRUST INC
BMR
| $311K | 0.01% |
+14,459
| New | +$308K |
|
491
Lockheed Martin
LMT
$135B
| $310K | 0.01% |
+1,610
| New | +$299K |
|
492
Unum
UNM
$14.2B
| $310K | 0.01% |
+8,881
| New | +$300K |
|
493
Maximus
MMS
$3.19B
| $309K | 0.01% |
+5,637
| New | +$274K |
|
|
EOX
494
DELISTED
EMERALD OIL INC (MT)
EOX
| $309K | 0.01% |
12,856
-13,503
| -51% | -$733K |
|
|
INFA
495
DELISTED
INFORMATICA CORP
INFA
| $308K | 0.01% |
8,069
-168,881
| -95% | -$6.06M |
|
|
RTN
496
DELISTED
Raytheon Company
RTN
| $306K | 0.01% |
+2,826
| New | +$292K |
|
497
Targa Resources
TRGP
$56B
| $299K | 0.01% |
+2,823
| New | +$327K |
|
|
ALJ
498
DELISTED
Alon USA Energy Inc
ALJ
| $296K | 0.01% |
+23,401
| New | +$336K |
|
499
Everest Group
EG
$14.3B
| $293K | 0.01% |
+1,722
| New | +$291K |
|
|
XLS
500
DELISTED
EXELIS INC COM STK
XLS
| $293K | 0.01% |
+16,732
| New | +$289K |
|
Similar funds
FNBT
SAG
ACI
RC
A
CGL
CB
JCM
UBS O'Connor's Q4 2014 Portfolio in Review
As of Q4 2014, UBS O'Connor held 798 positions worth $5.75B, down 0.68% from $5.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS O'Connor withdrew a net $636M in Q4 2014, closing 170 positions and reducing 128 holdings. Its most notable exit was NCR Voyix, an estimated $64.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, UBS O'Connor opened a new position in CAREFUSION CORPORATION worth $129M.
- UBS O'Connor's largest Q4 2014 buy was CAREFUSION CORPORATION: 2,168,433 shares worth $129M.
- UBS O'Connor added most to Allergan Inc in Q4 2014, an estimated $71.6M increase.
- UBS O'Connor's biggest Q4 2014 reduction was Alibaba, cutting an estimated $72.3M.
- UBS O'Connor fully exited NCR Voyix in Q4 2014, selling an estimated $64.1M.
- UBS O'Connor's ten largest holdings make up 22% of its $5.75B portfolio in Q4 2014.
- UBS O'Connor opened 336 new positions and closed 170 in Q4 2014.
- UBS O'Connor's portfolio value fell 0.68% quarter-over-quarter to $5.75B.
Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.